• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院儿童严重呼吸道合胞病毒疾病的相关因素:一项回顾性分析。

Factors associated with severe respiratory syncytial virus disease in hospitalised children: a retrospective analysis.

作者信息

Anderson Jeremy, Oeum Michelle, Verkolf Eva, Licciardi Paul V, Mulholland Kim, Nguyen Cattram, Chow Kim, Waller Gregory, Costa Anna-Maria, Daley Andrew, Crawford Nigel W, Babl Franz E, Duke Trevor, Do Lien Anh Ha, Wurzel Danielle

机构信息

Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia

Department of Paediatrics, The University of Melbourne - Parkville Campus, Melbourne, Victoria, Australia.

出版信息

Arch Dis Child. 2022 Apr;107(4):359-364. doi: 10.1136/archdischild-2021-322435. Epub 2021 Sep 15.

DOI:10.1136/archdischild-2021-322435
PMID:34526293
Abstract

BACKGROUND

Early recognition of children at risk of severe respiratory syncytial virus (RSV) lower respiratory tract infection is important as it informs management decisions. We aimed to evaluate factors associated with severe disease among young children hospitalised with RSV infection.

METHODS

We conducted a retrospective cohort study of all children <2 years of age hospitalised for RSV lower respiratory tract infection at a single tertiary paediatric hospital over three RSV seasons (January 2017-December 2019). We classified children as having 'moderate' or 'severe' disease based on the level of respiratory intervention and used univariable and multivariable regression models to determine factors associated with severe disease.

RESULTS

Of 970 hospitalised children, 386 (40%) were classified as having 'severe' and 584 (60%) as having 'moderate' RSV disease. On multivariable analyses, age <2 months (OR: 2.3, 95% CI 1.6 to 3.3, p<0.0001), prematurity (OR: 1.6, 95% CI 1.1 to 2.4, p=0.02) and RSV-parainfluenza virus type 3 (PIV3) codetection (OR: 2.6, 95% CI 1.05 to 6.5, p=0.04) were independently associated with severe disease.

CONCLUSION

Younger age, prematurity and PIV3 codetection were associated with severe RSV disease in children <2 years of age hospitalised with RSV infection. The association between PIV3 and severe RSV disease is a novel finding and warrants further investigation.

摘要

背景

早期识别有患严重呼吸道合胞病毒(RSV)下呼吸道感染风险的儿童很重要,因为这可为管理决策提供依据。我们旨在评估因RSV感染住院的幼儿中与严重疾病相关的因素。

方法

我们对一家三级儿科医院在三个RSV流行季节(2017年1月至2019年12月)因RSV下呼吸道感染住院的所有2岁以下儿童进行了一项回顾性队列研究。我们根据呼吸干预水平将儿童分为“中度”或“重度”疾病,并使用单变量和多变量回归模型来确定与严重疾病相关的因素。

结果

在970名住院儿童中,386名(40%)被分类为患有“重度”RSV疾病,584名(60%)被分类为患有“中度”RSV疾病。多变量分析显示,年龄<2个月(比值比:2.3,95%置信区间1.6至3.3,p<0.0001)、早产(比值比:1.6,95%置信区间1.1至2.4,p=0.02)和RSV与3型副流感病毒(PIV3)共同检测(比值比:2.6,95%置信区间1.05至6.5,p=0.04)与严重疾病独立相关。

结论

年龄较小、早产和PIV3共同检测与因RSV感染住院的2岁以下儿童的严重RSV疾病相关。PIV3与严重RSV疾病之间的关联是一项新发现,值得进一步研究。

相似文献

1
Factors associated with severe respiratory syncytial virus disease in hospitalised children: a retrospective analysis.住院儿童严重呼吸道合胞病毒疾病的相关因素:一项回顾性分析。
Arch Dis Child. 2022 Apr;107(4):359-364. doi: 10.1136/archdischild-2021-322435. Epub 2021 Sep 15.
2
Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital.与塔玛萨大学医院住院儿童严重呼吸道合胞病毒感染相关的因素。
F1000Res. 2024 May 17;13:231. doi: 10.12688/f1000research.146540.2. eCollection 2024.
3
Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes.住院呼吸道合胞病毒病及其严重结局的危险因素。
Influenza Other Respir Viruses. 2020 Nov;14(6):658-670. doi: 10.1111/irv.12729. Epub 2020 Feb 16.
4
Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.人偏肺病毒与呼吸道合胞病毒的比较:病毒共检测、基因型及重症疾病的危险因素
PLoS One. 2017 Jan 17;12(1):e0170200. doi: 10.1371/journal.pone.0170200. eCollection 2017.
5
[Clinical characteristics of hospitalized children with respiratory syncytial virus infection and risk prediction of severe illness during the post-COVID-19 era in Kunming].[昆明市新冠疫情后时代呼吸道合胞病毒感染住院儿童的临床特征及重症风险预测]
Zhonghua Er Ke Za Zhi. 2024 Mar 25;62(4):323-330. doi: 10.3760/cma.j.cn112140-20240219-00109.
6
Hospitalization rate of respiratory syncytial virus-associated acute lower respiratory infection among young children in Suzhou, China, 2010-2014.2010-2014 年中国苏州地区婴幼儿呼吸道合胞病毒相关急性下呼吸道感染的住院率。
Influenza Other Respir Viruses. 2022 Jul;16(4):789-799. doi: 10.1111/irv.12958. Epub 2022 Jan 5.
7
Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia.马来西亚吉兰丹州与呼吸道合胞病毒相关的下呼吸道感染的流行率、危险因素和临床特征。
J Med Virol. 2019 Sep;91(9):1608-1615. doi: 10.1002/jmv.25500. Epub 2019 May 29.
8
Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection.因急性下呼吸道感染住院儿童的呼吸道合胞病毒感染
S Afr Med J. 2000 May;90(5):509-12.
9
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia.2018 年澳大利亚因呼吸道合胞病毒住院治疗的五岁以下儿童年度费用负担。
Commun Dis Intell (2018). 2022 Feb 16;46. doi: 10.33321/cdi.2022.46.5.
10
Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017.2014-2017 年德国南部海德堡住院儿童呼吸道合胞病毒的分子流行病学研究。
Infect Genet Evol. 2022 Mar;98:105209. doi: 10.1016/j.meegid.2022.105209. Epub 2022 Jan 12.

引用本文的文献

1
Who is at risk of a respiratory syncytial virus hospitalisation? A linked, population-based birth cohort analysis in children aged less than 5 years.哪些人有因呼吸道合胞病毒住院的风险?一项针对5岁以下儿童的基于人群的关联出生队列分析。
Lancet Reg Health West Pac. 2025 Aug 8;61:101654. doi: 10.1016/j.lanwpc.2025.101654. eCollection 2025 Aug.
2
Respiratory syncytial virus preventives for children in Australia: current landscape and future directions.澳大利亚儿童呼吸道合胞病毒预防措施:现状与未来方向
Med J Aust. 2025 Jun 16;222(11):579-586. doi: 10.5694/mja2.52671. Epub 2025 May 25.
3
Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
人类呼吸道合胞病毒生物学:免疫反应及抗病毒机制的当前观点
Virus Res. 2024 Dec;350:199483. doi: 10.1016/j.virusres.2024.199483. Epub 2024 Oct 18.
4
Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study.比较 COVID-19 前后时期因呼吸道合胞病毒感染住院的儿童的特征:一项多中心回顾性研究。
BMC Infect Dis. 2024 Sep 19;24(1):1009. doi: 10.1186/s12879-024-09783-2.
5
A novel combined nomogram for predicting severe acute lower respiratory tract infection in children hospitalized for RSV infection during the post-COVID-19 period.一种用于预测新冠疫情后因呼吸道合胞病毒(RSV)感染住院儿童严重急性下呼吸道感染的新型联合列线图。
Front Immunol. 2024 Jul 24;15:1437834. doi: 10.3389/fimmu.2024.1437834. eCollection 2024.
6
A Scoring System to Predict Severe Acute Lower Respiratory Infection in Children Caused by Respiratory Syncytial Virus.一种预测呼吸道合胞病毒引起的儿童严重急性下呼吸道感染的评分系统。
Microorganisms. 2024 Jul 12;12(7):1411. doi: 10.3390/microorganisms12071411.
7
Epidemiology of respiratory syncytial virus in hospitalized children before, during, and after the COVID-19 lockdown restriction measures in Greece.希腊在 COVID-19 封锁限制措施实施前后,对住院儿童中呼吸道合胞病毒的流行病学研究。
Epidemiol Infect. 2024 May 13;152:e94. doi: 10.1017/S0950268824000724.
8
Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis.澳大利亚 0-6 月龄婴儿呼吸道合胞病毒疾病发病率:系统评价与叙述性综合。
BMC Public Health. 2023 Dec 21;23(1):2560. doi: 10.1186/s12889-023-17474-x.
9
Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease.帕利珠单抗预防严重呼吸道合胞病毒(RSV)疾病的安全性、有效性和耐受性综述。
Drug Healthc Patient Saf. 2023 Sep 11;15:103-112. doi: 10.2147/DHPS.S348727. eCollection 2023.
10
Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children.住院儿童严重呼吸道合胞病毒感染的危险因素。
Viruses. 2023 Aug 9;15(8):1713. doi: 10.3390/v15081713.